German pharmaceutical group Henkel has acquired a stake of 6.86 per cent in the
share capital of Wella. Through a subsidiary, the group obtained
4.99 per cent of the common shares and 10.38 per cent of the
preferred non voting shares.
The latest topical anti-aging advancements come from a new
understanding of the importance of peptides, writes Procter &
Gamble. According to the company, the introduction of its Olay
Regenerist with Olay-exclusive Amino-Peptide...
CP Kelco, a global leader in hydrocolloids, has added Keltrol CG
xanthan gum range, designed specifically for personal care
applications and beta pectin for use in lotions, to its product
range at the European cosmetic exhibition...
The recent unveiling of Sara Lee's instant foam Delial suncare
products - to be sold throughout Europe - is further proof that
easy-to-use one-touch foamers from Airspray International have made
rapid inroads into another consumer...
Roche Vitamins is to start production of pure epigallocatechin
gallate (EGCG), the active compound in green tea, at a new
production plant in Shanghai. Annual output is expected to be more
than 40 tons.
Leading packaging firm Rexam Closures & Containers has
announced the FGC for personal care and beauty applications. The FG
extension is targeted for personal care products impacted by the
new CPSC Hydrocarbon regulation.
Symrise - the new fragrance and flavour synergy. Just four months
after the European Commission gave equity group EQT the all clear
to buy two leading German-based fragrance and flavour producers -
Haarmann & Reimer and Dragoco...
Jim Bigham has been appointed director of sales and marketing,
Closures at US cosmetic packaging company Risdon-AMS. In a
statement this week, the company said Bigham will be responsible
for directing sales and marketing efforts for...
Mothers who supplement their diet with fatty acids rich in
docosahexaenoic acid (DHA) during pregnancy and lactation may be
doing their children a favour in later years, say researchers in
this month's Pediatrics journal.
The research laboratory Bio-Technical Resources today announced it
is commercialising its technology to produce glucosamine by
microbial fermentation, with product availability in the first
quarter of 2003.